1.B. Sitagliptin plus Glargine Group.
Discontinue oral antidiabetic drugs or low-dose insulin on admission.
Sitagliptin once daily -Dosage  100 mg/day (at any time of day) for patients with GFR 50-100 ml/min  50 mg/day for patients with GFR 30-50 ml/min Glargine once daily -starting daily dose:
 Patients with BG between 140-200 mg/dL= 0.2 units per kg weight per day.
 Patients with BG between 201-400 mg/dL= 0.25 units per kg weight per day.
 Glargine insulin will be given once daily, at the same time of the day.
 Patients will receive the full-dose of glargine insulin (even if NPO) except for those that have GFR <50 ml/min. Patients with GFR <50ml/min will receive only ½ of the calculated insulin dose.
Supplemental (correction) insulin:
 Give supplemental insulin lispro following the "sliding scale" protocol (1D) for blood glucose > 140 mg/dl.  If a patient is able and expected to eat all, give supplemental lispro insulin before each meal and at bedtime following the "usual" column.
 If a patient is not able to eat, give supplemental lispro insulin every 6 hours (6-12-6-12) following the "sensitive" column.
Daily insulin adjustment:
 Fasting and pre-meal BG between 100-140 mg/dl without hypoglycemia the previous day: no change  Fasting and pre-meal BG between 141-180 mg/dl: increase glargine dose by 10% every day  Fasting and pre-meal BG >180 mg/dl: increase glargine dose by 20% every day  Fasting and pre-meal BG between 70-99 mg/dl: decrease glargine dose by 10% every day  If a patient develops hypoglycemia (BG <70 mg/dL), decrease glargine dose by 20%.
 If a patient develops hypoglycemia (BG <40 mg/dL), decrease glargine dose by 30-40%.
Blood glucose monitoring:
 Measure BG before each meal and at bedtime (or every 6 hours if a patient is not eating) using a glucose meter. In addition, measure BG at any time if a patient experiences symptoms of hypoglycemia.
1.C. Basal Bolus Insulin Regimen
Starting total daily insulin dose:
 Patients with BG between 140-200 mg/dL= 0.4 units per kg weight per day.
 Patients with BG between 201-400 mg/dL= 0.5 units per kg weight per day.
 Half of total daily dose will be given as glargine and half as lispro/aspart.
 Glargine insulin will be given once daily, at the same time of the day. Patients will receive the full-dose of glargine insulin (even if NPO) except for those that have GFR <50 ml/min. Patients with GFR <50ml/min will receive only ½ of the calculated insulin dose.
 Insulin lispro will be given in three equally divided doses before each meal. To prevent hypoglycemia, if a subject is not able to eat, the dose of lispro will be held. Patients with GFR <50ml/min receive ½ of the calculated insulin dose.
Daily insulin adjustment:
Supplemental (correction) insulin:
Blood glucose monitoring:
 Measure BG before each meal and at bedtime (or every 6 hours if a patient is not eating) using a glucose meter. In addition, measure BG at any time if a patient experiences symptoms of hypoglycemia. 
